#biotechnology
#biotechnology

A cell pulls off one of the 'Holy Grails' of biotechnology

A groundbreaking discovery reveals that a complex single-celled alga can convert nitrogen, potentially revolutionizing agriculture and reducing reliance on synthetic fertilizers.

Strong, flexible 'nylon' made by engineered bacteria for the first time

Researchers have created genetically engineered microbes that produce nylon-like plastics, offering a potential solution to plastic waste.

In other news this week: ZeroNorth secures 48.1M+, and more

A range of startups, including Leafr and Ignota Labs, have secured significant funding to innovate in sustainability and drug development.

fromTNW | Sustainability

Startup uses ancient bacteria to turn Texas CO2 into green chemicals

Again is building a new bioreactor plant in Texas to convert CO2 into sustainable chemicals using ancient bacteria, aiming for substantial emissions reduction.

fromIPWatchdog.com | Patents & Intellectual Property Law

Green Innovation in Brazil: How Patent Protection Is Powering Sustainable Agriculture

Brazil is poised to lead in agricultural biological agents due to its biodiversity and climate.

It's time to hit the reset button on GMOs

GMO 2.0 is set to revolutionize agriculture with innovative technologies aiding sustainability and efficiency, addressing global food demand.

US news

A cell pulls off one of the 'Holy Grails' of biotechnology

A groundbreaking discovery reveals that a complex single-celled alga can convert nitrogen, potentially revolutionizing agriculture and reducing reliance on synthetic fertilizers.

Strong, flexible 'nylon' made by engineered bacteria for the first time

Researchers have created genetically engineered microbes that produce nylon-like plastics, offering a potential solution to plastic waste.

In other news this week: ZeroNorth secures 48.1M+, and more

A range of startups, including Leafr and Ignota Labs, have secured significant funding to innovate in sustainability and drug development.

fromTNW | Sustainability

Startup uses ancient bacteria to turn Texas CO2 into green chemicals

Again is building a new bioreactor plant in Texas to convert CO2 into sustainable chemicals using ancient bacteria, aiming for substantial emissions reduction.

fromIPWatchdog.com | Patents & Intellectual Property Law

fromNon Profit News | Nonprofit Quarterly

Green Innovation in Brazil: How Patent Protection Is Powering Sustainable Agriculture

Brazil is poised to lead in agricultural biological agents due to its biodiversity and climate.

Belgian firm 4Tissue raises 1.5M to advance bioresorbable hydrogel for breast reconstruction - Silicon Canals

4Tissue has secured â¬1.5M funding to advance bioresorbable hydrogel technology for breast reconstruction and tissue regeneration.

Cancer

Cancer Research in the US Is World Class Because of Its Broad Base of Funding-with the Government Pulling Out, Its Future Is Uncertain - Non Profit News | Nonprofit Quarterly

The complex ecosystem of U.S. cancer research is threatened by funding instability and political shifts.

German biotech firm SenseUP closes 2.4M Seed round

SenseUP secures €2.4M Seed funding to develop sustainable biopesticides for agriculture.

Marketing tech

In other news this week: Granite Bio emerges from stealth with 87.6M, Didomi bags 72M, First Momentum Ventures closes 35M, and more - Silicon Canals

Startup companies

Amsterdam's Avidicure exits stealth mode with 43.8M to develop new antibody therapies - Silicon Canals

Startup companies

Leuven-based Augustine Therapeutics raises 77.7M to advance neuromuscular drug development - Silicon Canals

fromNon Profit News | Nonprofit Quarterly

Belgian firm 4Tissue raises 1.5M to advance bioresorbable hydrogel for breast reconstruction - Silicon Canals

4Tissue has secured â¬1.5M funding to advance bioresorbable hydrogel technology for breast reconstruction and tissue regeneration.

Cancer

Cancer Research in the US Is World Class Because of Its Broad Base of Funding-with the Government Pulling Out, Its Future Is Uncertain - Non Profit News | Nonprofit Quarterly

The complex ecosystem of U.S. cancer research is threatened by funding instability and political shifts.

German biotech firm SenseUP closes 2.4M Seed round

SenseUP secures €2.4M Seed funding to develop sustainable biopesticides for agriculture.

Marketing tech

In other news this week: Granite Bio emerges from stealth with 87.6M, Didomi bags 72M, First Momentum Ventures closes 35M, and more - Silicon Canals

Startup companies

Amsterdam's Avidicure exits stealth mode with 43.8M to develop new antibody therapies - Silicon Canals

Startup companies

Leuven-based Augustine Therapeutics raises 77.7M to advance neuromuscular drug development - Silicon Canals

Tech firms are cashing in on the bizarre science of organ preservation

The evolution of organ transplantation technology is creating new business opportunities.

OrganOx's innovative liver preservation technology enhances transplant success rates by extending organ viability.

Xenotransplantation using gene-edited pig organs is emerging as a solution for organ shortages.

Medicine

World first: ultra-powerful CRISPR treatment trialled in a person

Prime editing has been used successfully in a patient for the first time, offering hope for rare disease treatments.

OMG science

The world's first genetically modified spider could lead to new 'supermaterials'

fromBerlin Art Link

OMG science

Emilia Tikka Studio Visit | Berlin Art Link

fromTNW | Deep-Tech

Tech firms are cashing in on the bizarre science of organ preservation

The evolution of organ transplantation technology is creating new business opportunities.

OrganOx's innovative liver preservation technology enhances transplant success rates by extending organ viability.

Xenotransplantation using gene-edited pig organs is emerging as a solution for organ shortages.

Medicine

World first: ultra-powerful CRISPR treatment trialled in a person

Prime editing has been used successfully in a patient for the first time, offering hope for rare disease treatments.

OMG science

The world's first genetically modified spider could lead to new 'supermaterials'

fromBerlin Art Link

OMG science

Emilia Tikka Studio Visit | Berlin Art Link

Meet the 'woolly mouse': why scientists doubt it's a big step towards recreating mammoths

Colossal Biosciences announces breakthrough with genetic manipulation of mice, aimed at de-extincting woolly mammoths.

fromThe Washington Post

23andMe thought its DNA data would help research. Then reality hit.

23andMe's decline from a $6 billion valuation culminated in Chapter 11 bankruptcy amid unsuccessful business ventures and market challenges.

CEO Anne Wojcicki resigned but expressed continued belief in the company's potential.

fromThe New Yorker

Inside the Lab Where Scientists Are Bringing Back Extinct Animals

A genetics startup has successfully created three pups containing ancient DNA of the extinct dire wolf.

fromThe Verge

23andMe and its user data will soon belong to a pharmaceutical giant

23andMe will continue its DNA testing services following acquisition by Regeneron Pharmaceuticals, ensuring privacy protections and customer data management remain in place.

fromHarvard Business Review

Artificial intelligence

'We have a way of steering a fly like you would a car' - Harvard Gazette

OMG science

Building Effective Partnerships to Power Life Sciences Innovation - SPONSOR CONTENT FROM ASTELLAS

Meet the 'woolly mouse': why scientists doubt it's a big step towards recreating mammoths

Colossal Biosciences announces breakthrough with genetic manipulation of mice, aimed at de-extincting woolly mammoths.

fromThe Washington Post

23andMe thought its DNA data would help research. Then reality hit.

23andMe's decline from a $6 billion valuation culminated in Chapter 11 bankruptcy amid unsuccessful business ventures and market challenges.

CEO Anne Wojcicki resigned but expressed continued belief in the company's potential.

fromThe New Yorker

Inside the Lab Where Scientists Are Bringing Back Extinct Animals

A genetics startup has successfully created three pups containing ancient DNA of the extinct dire wolf.

fromThe Verge

23andMe and its user data will soon belong to a pharmaceutical giant

23andMe will continue its DNA testing services following acquisition by Regeneron Pharmaceuticals, ensuring privacy protections and customer data management remain in place.

fromHarvard Business Review

Artificial intelligence

'We have a way of steering a fly like you would a car' - Harvard Gazette

OMG science

Building Effective Partnerships to Power Life Sciences Innovation - SPONSOR CONTENT FROM ASTELLAS

FDA-Approved Artificial Blood Vessel Stirs Concerns

FDA approved Humacyte's lab-grown blood vessels despite serious patient complications, raising concerns about study validation and patient safety.

Coronavirus

Moderna withdraws application for US approval of combined flu-Covid shot

London startup

fromwww.nytimes.com

FDA-Approved Artificial Blood Vessel Stirs Concerns

FDA approved Humacyte's lab-grown blood vessels despite serious patient complications, raising concerns about study validation and patient safety.

Coronavirus

Moderna withdraws application for US approval of combined flu-Covid shot

Marketing tech

Biotech company Regeneron buying 23andMe for $256 million

Privacy professionals

Biotech company Regeneron to buy bankrupt 23andMe for $256M

Career

How I honed my biopharma dealmaking and business-development skills after my PhD

fromABC7 San Francisco

Marketing tech

Biotechnology company Regeneron buying bankrupt 23andMe for $256M

fromThe Mercury News

Marketing tech

Biotech company Regeneron buying 23andMe for $256 million

Privacy professionals

Biotech company Regeneron to buy bankrupt 23andMe for $256M

Career

How I honed my biopharma dealmaking and business-development skills after my PhD

fromABC7 San Francisco

Marketing tech

Biotechnology company Regeneron buying bankrupt 23andMe for $256M

more#acquisition

#mosquito-control

Public health

GM mosquitoes: inside the lab breeding six-legged agents in the war on malaria

Genetically modified mosquitoes could significantly impact malaria control efforts.

fromThe Local France

France politics

French start-up unveils plan to sterilise mosquitoes

Public health

GM mosquitoes: inside the lab breeding six-legged agents in the war on malaria

Genetically modified mosquitoes could significantly impact malaria control efforts.

fromThe Local France

France politics

French start-up unveils plan to sterilise mosquitoes

more#mosquito-control

Exclusive: Fieldstone Bio is building microbes that can sense everything from TNT to arsenic | TechCrunch

They've evolved to sense and respond to information. It's just trillions of calculations going on at all times all around us.

Marketing tech

#artificial-intelligence

Four ways to power-up AI for drug discovery

AI has the potential to greatly enhance the drug discovery process by addressing the challenges of cost and time.

These 10 biotech companies are changing how we discover new drugs and treat complex diseases

Biotech companies are harnessing AI and cutting-edge research tools to enhance drug development and diagnostics.

US politics

How political attacks could crush the mRNA vaccine revolution

fromZDNET

Artificial intelligence

This AI-designed drug for IBD was just given to human subjects for the first time

Tech industry

These States Are Driving 21st Century Technology Faster Than the Rest

Artificial intelligence

Anthropic launches a program to support scientific research | TechCrunch

Four ways to power-up AI for drug discovery

AI has the potential to greatly enhance the drug discovery process by addressing the challenges of cost and time.

These 10 biotech companies are changing how we discover new drugs and treat complex diseases

Biotech companies are harnessing AI and cutting-edge research tools to enhance drug development and diagnostics.

US politics

How political attacks could crush the mRNA vaccine revolution

Donald Trump's second term's first day featured a major AI investment, signaling support for transformative mRNA technology intended for personalized cancer treatments.

fromZDNET

This AI-designed drug for IBD was just given to human subjects for the first time

Absci is the first company to initiate a Phase I trial for a drug completely developed by AI.

Tech industry

These States Are Driving 21st Century Technology Faster Than the Rest

California and Massachusetts remain key players in technological innovation, with a focus on AI and biotech respectively.

more#artificial-intelligence

Artificial intelligence

Anthropic launches a program to support scientific research | TechCrunch

Intellectual property law

fromPatently-O

The Standard for Conception: Don't Ask "Will it Work"

The Federal Circuit vacated a PTAB decision on CRISPR-Cas9, citing an incorrect legal standard for conception in patent law.

#environmental-science

fromPhys

Microbes in Brooklyn superfund site teach lessons on fighting industrial pollution

Microorganisms in Gowanus Canal have developed extensive pollution-fighting genes, offering potential for sustainable waterway cleanup.

Genetic-engineered bacteria break down industrial contaminants

Researchers have engineered a single bacterial strain capable of degrading multiple industrial contaminants using genes from diverse bacterial species.

fromPhys

Microbes in Brooklyn superfund site teach lessons on fighting industrial pollution

Microorganisms in Gowanus Canal have developed extensive pollution-fighting genes, offering potential for sustainable waterway cleanup.

more#environmental-science

Genetic-engineered bacteria break down industrial contaminants

Researchers have engineered a single bacterial strain capable of degrading multiple industrial contaminants using genes from diverse bacterial species.

A startup plans to make money from reviving the woolly mammoth. Here's how.

Colossal Biosciences aims to revive extinct species, leveraging advancements in biotechnology to create new revenue streams and innovations.

UK's Epoch Biodesign secures 17.1M in Series A

Epoch Biodesign raised $18.3M to enhance enzyme technology for improved plastic recycling over traditional methods.

CRISPR Therapeutics (CRSP) Short Sellers Have A Lot Riding on Earnings

CRISPR Therapeutics is facing significant challenges with declining stock performance and heightened short interest.

European startups

In other news this week: BayWa r.e. secures 435M, evroc gets Europe's largest Series A funding, Sofinnova Partners raises 165M and more - Silicon Canals

NYC startup

NewLimit, founded by Coinbase CEO Brian Armstorng, raises $130M to develop age-reversing treatments | TechCrunch

fromBusiness Insider

A startup plans to make money from reviving the woolly mammoth. Here's how.

Colossal Biosciences aims to revive extinct species, leveraging advancements in biotechnology to create new revenue streams and innovations.

UK's Epoch Biodesign secures 17.1M in Series A

Epoch Biodesign raised $18.3M to enhance enzyme technology for improved plastic recycling over traditional methods.

CRISPR Therapeutics (CRSP) Short Sellers Have A Lot Riding on Earnings

CRISPR Therapeutics is facing significant challenges with declining stock performance and heightened short interest.

European startups

In other news this week: BayWa r.e. secures 435M, evroc gets Europe's largest Series A funding, Sofinnova Partners raises 165M and more - Silicon Canals

NYC startup

NewLimit, founded by Coinbase CEO Brian Armstorng, raises $130M to develop age-reversing treatments | TechCrunch

Four rising stars at the forefront of cancer research

Young researchers are innovating in cancer drug development, focusing on pioneering techniques like cancer reversion to reduce the need for traditional treatments.

Startup companies

Bay Area biotech company slashes staff after losing $655 million in value

NYC startup

Bay Area biotech company once worth $700M lays off entire workforce

Cancer

Four rising stars at the forefront of cancer research

Young researchers are innovating in cancer drug development, focusing on pioneering techniques like cancer reversion to reduce the need for traditional treatments.

Startup companies

Bay Area biotech company slashes staff after losing $655 million in value

NYC startup

Bay Area biotech company once worth $700M lays off entire workforce

more#drug-development

Purses made from T. rex? This company claims leather made from 66 million-year-old dinosaur DNA is coming

Lab-grown leather from T. rex DNA represents a breakthrough in sustainable luxury fashion.

OMG science

Project Says It's Recreating Dinosaur Skin to Make T-Rex Leather

fromNew York Post

Purses made from T. rex? This company claims leather made from 66 million-year-old dinosaur DNA is coming

Lab-grown leather from T. rex DNA represents a breakthrough in sustainable luxury fashion.

OMG science

Project Says It's Recreating Dinosaur Skin to Make T-Rex Leather

more#sustainable-fashion

#immunology

Coronavirus

COVID-flu vaccine could provide broad, lasting protection | Cornell Chronicle

A new vaccine platform from Cornell researchers offers longer-lasting protection against COVID-19 and influenza, showing promising results in mouse models.

Snake collector's immunity quest opens path towards universal antivenom

Tim Friede's self-experimentation offers a groundbreaking approach to developing a universal antivenom for snake bites.

Bay Area man who injected himself with venom hundreds of times could revolutionize snakebite treatment

Tim Friede's unique exposure to snake venom has led to the development of an antivenom for 19 snake species, showcasing new possibilities in snakebite treatment.

Coronavirus

COVID-flu vaccine could provide broad, lasting protection | Cornell Chronicle

A new vaccine platform from Cornell researchers offers longer-lasting protection against COVID-19 and influenza, showing promising results in mouse models.

Snake collector's immunity quest opens path towards universal antivenom

Tim Friede's self-experimentation offers a groundbreaking approach to developing a universal antivenom for snake bites.

Bay Area man who injected himself with venom hundreds of times could revolutionize snakebite treatment

Tim Friede's unique exposure to snake venom has led to the development of an antivenom for 19 snake species, showcasing new possibilities in snakebite treatment.

more#immunology

Belfast-based AMPLY Discovery completes 1.5M seed funding

Ten years ago, I began combining financial modeling expertise with computational biology to create a drug discovery platform. Evolution has spent billions of years perfecting natural defence mechanisms, and now we're using AI to unlock this wisdom.

London startup

This Gene Therapy Startup Wants to Change the Way We Age | Entrepreneur

Minicircle aims to slow aging and enhance biological function through a quick gene therapy injection.

fromSlate Magazine

Pets

This Pill Promises to Give Your Dog More Years. You Might Not Like What Comes With Them.

Growth hacking

fromEntrepreneur

4 weeks ago

This Gene Therapy Startup Wants to Change the Way We Age | Entrepreneur

Minicircle aims to slow aging and enhance biological function through a quick gene therapy injection.

fromSlate Magazine

Pets

This Pill Promises to Give Your Dog More Years. You Might Not Like What Comes With Them.

Opinion | The White House Tech Bros Owe Their Fortunes to the Research They're Killing

University research is essential for America's entrepreneurial culture and technological advancements.

London startup

fromTNW | Deep-Tech

Fertility startup 'rejuvenates' human eggs to boost chances of conception

Ovo Labs is developing technologies to enhance IVF success rates by rejuvenating human eggs, aiming to lower genetic errors and increase conception chances.

Colossal says creating woolly mice is a 'validation step' for de-extinction and could help eradicate diseases

Colossal Biosciences achieved a milestone by genetically engineering woolly mice, marking a significant step towards woolly mammoth de-extinction.

fromInsideHook

Have Scientists Created Hybrids of Mice and Mammoths?

Colossal's latest project involves gene-edited mice simulating wooly mammoth traits, raising questions about de-extinction efforts.

fromwww.scientificamerican.com

Company Seeking to Resurrect the Woolly Mammoth Creates a 'Woolly Mouse'

Colossal Biosciences introduces lab-created woolly mice as a step toward reviving extinct species, emphasizing genetic engineering's role in enhancing resilience against climate change.

Scientists aiming to bring back woolly mammoth create woolly mice

Scientists create genetically modified woolly mice as a step toward reviving woolly mammoths.

These scientists are trying to revive woolly mammoths ... by modifying mice

Colossal Biosciences has created genetically modified mice resembling woolly mammoths as a step toward de-extinction.

fromenglish.elpais.com

The company that created woolly mice announces the de-extinction' of the dire wolf

Colossal Biosciences has reportedly de-extincted the dire wolf using genetic engineering techniques.

Colossal says creating woolly mice is a 'validation step' for de-extinction and could help eradicate diseases

Colossal Biosciences achieved a milestone by genetically engineering woolly mice, marking a significant step towards woolly mammoth de-extinction.

fromInsideHook

Have Scientists Created Hybrids of Mice and Mammoths?

Colossal's latest project involves gene-edited mice simulating wooly mammoth traits, raising questions about de-extinction efforts.

fromwww.scientificamerican.com

Company Seeking to Resurrect the Woolly Mammoth Creates a 'Woolly Mouse'

Colossal Biosciences introduces lab-created woolly mice as a step toward reviving extinct species, emphasizing genetic engineering's role in enhancing resilience against climate change.

Scientists aiming to bring back woolly mammoth create woolly mice

Scientists create genetically modified woolly mice as a step toward reviving woolly mammoths.

These scientists are trying to revive woolly mammoths ... by modifying mice

Colossal Biosciences has created genetically modified mice resembling woolly mammoths as a step toward de-extinction.

fromenglish.elpais.com

The company that created woolly mice announces the de-extinction' of the dire wolf

Colossal Biosciences has reportedly de-extincted the dire wolf using genetic engineering techniques.

What's in a Name: Cure51 Co-founder Nicolas Wolikow on honouring Rosalind Franklin and one of the most important photos ever taken - Silicon Canals

Cure51 aims to revolutionize oncology by creating the first global database of cancer survivors and seeking new treatments based on survivor data.

UK & US-based healthtech startup Level Zero Health bags 6.63M

Level Zero Health has secured Â£5.5M in pre-seed funding to develop continuous hormone monitoring technology using DNA-based sensors.

European startups

Dutch healthtech startups that raised funding in 2025

Fundraising

UK & US-based healthtech startup Level Zero Health bags 6.63M

Level Zero Health has secured Â£5.5M in pre-seed funding to develop continuous hormone monitoring technology using DNA-based sensors.

European startups

Dutch healthtech startups that raised funding in 2025

Journal targeted by paper mill still grappling with the aftermath years later

Despite claims of addressing the issue, Bioengineered still contains hundreds of dubious papers linked to paper mills.

Mental health

fromBig Think

The next era of psychedelics may be precision-designed states of consciousness

Mindstate Design Labs aims to create predictable psychedelic experiences for improved mental health treatment.

Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private Equity - MedCity News

Bluebird Bio has agreed to sell itself to private equity firms Carlyle and SK Capital for $29 million to stabilize its gene therapy commercialization efforts.

FDA approves siRNA drug for haemophilia prophylaxis

Fitusiran has received FDA approval for hemophilia prophylaxis, with a dosing schedule that enhances convenience for patients.

SF food

Tiny Silicon Valley drugmaker soars on FDA win to treat never-ending hunger

Venture

fromMedCity News

Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private Equity - MedCity News

Bluebird Bio has agreed to sell itself to private equity firms Carlyle and SK Capital for $29 million to stabilize its gene therapy commercialization efforts.

FDA approves siRNA drug for haemophilia prophylaxis

Fitusiran has received FDA approval for hemophilia prophylaxis, with a dosing schedule that enhances convenience for patients.

SF food

Tiny Silicon Valley drugmaker soars on FDA win to treat never-ending hunger

more#fda-approval

#23andme

Privacy professionals

fromTheregister

Genetic data sharing service openSNP to close down

OpenSNP will shut down due to risks of genetic data misuse, especially following 23andMe's bankruptcy.

23andMe Is Selling All Your Data, in Largest Sale of Genomes in History

23andMe's DNA data from 15 million individuals is being auctioned, raising concerns about privacy versus potential scientific benefits.

Privacy professionals

fromTheregister

Genetic data sharing service openSNP to close down

OpenSNP will shut down due to risks of genetic data misuse, especially following 23andMe's bankruptcy.

Intellectual property law

23andMe Is Selling All Your Data, in Largest Sale of Genomes in History

23andMe's DNA data from 15 million individuals is being auctioned, raising concerns about privacy versus potential scientific benefits.

more#23andme

fromIPWatchdog.com | Patents & Intellectual Property Law

Strong IP Protections are the Key to Growing U.S. Manufacturing

Strengthening IP protections ensures that future products are not just designed but also manufactured in America.

#sustainable-agriculture

SF food

Gene-edited non-browning banana could cut food waste, scientists say

The genetically engineered non-browning banana offers a new solution to food waste by extending shelf life and resilience during transport.

NYC startup

The most innovative companies in agriculture for 2025

SF food

Gene-edited non-browning banana could cut food waste, scientists say

The genetically engineered non-browning banana offers a new solution to food waste by extending shelf life and resilience during transport.

more#sustainable-agriculture

NYC startup

The most innovative companies in agriculture for 2025

Silicon Valley food

fromwww.nytimes.com

For Patients Needing Transplants, Hope Arrives on Tiny Hooves

Cloned pigs are being raised in controlled conditions for potential use in human organ transplants, highlighting advances in biotechnology and ethical considerations.

fromWIRED

'Startup Nation' Groups Say They're Meeting Trump Officials to Push for Deregulated 'Freedom Cities'

Regulatory challenges hinder technological development despite available capital and political support.

#antibiotic-resistance

Harvard startup creating a new class of antibiotics - Harvard Gazette

Kinvard Bio aims to tackle antibiotic resistance by developing a new class of antibiotics to treat infections effectively.

Bacterial 'jumping genes' can target and control chromosome ends | Cornell Chronicle

Transposons play a crucial role in bacterial evolution and antibiotic resistance by moving within genomes.

Harvard startup creating a new class of antibiotics - Harvard Gazette

Kinvard Bio aims to tackle antibiotic resistance by developing a new class of antibiotics to treat infections effectively.

more#antibiotic-resistance

Bacterial 'jumping genes' can target and control chromosome ends | Cornell Chronicle

Transposons play a crucial role in bacterial evolution and antibiotic resistance by moving within genomes.

US news

fromwww.nytimes.com

China Targets U.S. Biotech Firm in Broadening Blacklist

China escalates trade conflict with the U.S. by banning Illumina, signaling a robust response to tariffs.

Venture

The Billionaire Baker Brothers Just Made This Big Biotech Stock Move

Billionaires Julian and Felix Baker significantly influence biotech investments through their hedge fund, Baker Bros. Advisors.

#healthcare

fromMedium

NVIDIA and Arc Institute Unveil Evo 2, a Groundbreaking Foundation Model for Biomolecular Sciences

Evo 2 is a groundbreaking AI model set to enhance biomolecular research through genomic data analysis.

Toronto startup

University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis | TechCrunch

Afynia Laboratories aims to revolutionize endometriosis diagnosis with a novel blood test utilizing microRNA biomarkers.

fromMedium

NVIDIA and Arc Institute Unveil Evo 2, a Groundbreaking Foundation Model for Biomolecular Sciences

Evo 2 is a groundbreaking AI model set to enhance biomolecular research through genomic data analysis.

Toronto startup

University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis | TechCrunch

Afynia Laboratories aims to revolutionize endometriosis diagnosis with a novel blood test utilizing microRNA biomarkers.

Bold red lipstick gets its color from crushed bugs. This biotech startup made a version that's insect-free

The classic red color of lipstick traditionally comes from carmine, but a new biotech alternative has emerged without using insects.

Silicon Valley

US court upholds Theranos founder Elizabeth Holmes's conviction

Elizabeth Holmes's conviction for defrauding investors in Theranos is upheld by a U.S. court, rejecting her appeal against the ruling.

Medicine

Why is it so hard to rewrite a genome?

Synthetic genomics has progressed significantly since the failed Big DNA Contest in 2004, demonstrating the importance of ambition and imagination in research.